DnB Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
12,300
-334
| -3% | -$6.8K | ﹤0.01% | 681 |
|
|
2025
Q1 | $229K | Buy |
12,634
+2,503
| +25% | +$45.4K | ﹤0.01% | 703 |
|
|
2024
Q4 | $256K | Sell |
10,131
-38
| -0.4% | -$960 | ﹤0.01% | 698 |
|
|
2024
Q3 | $346K | Buy |
10,169
+2,297
| +29% | +$78.1K | ﹤0.01% | 675 |
|
|
2024
Q2 | $292K | Buy |
7,872
+2,523
| +47% | +$93.5K | ﹤0.01% | 675 |
|
|
2024
Q1 | $224K | Buy |
+5,349
| New | +$224K | ﹤0.01% | 692 |
|